Plant Source Derived Compound Exhibited In Silico Inhibition of Membrane Glycoprotein In SARS-CoV-2: Paving the Way to Discover a New Class of Compound For Treatment of COVID-19

SARS-CoV-2 is the virus responsible for causing COVID-19 disease in humans, creating the recent pandemic across the world, where lower production of Type I Interferon (IFN-I) is associated with the deadly form of the disease. Membrane protein or SARS-CoV-2 M proteins are known to be the major reason...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahanta, Saurov, Naiya, Tufan, Biswas, Kunal, Changkakoti, Liza, Mohanta, Yugal Kishore, Tanti, Bhaben, Mishra, Awdhesh Kumar, Mohanta, Tapan Kumar, Sharma, Nanaocha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022603/
https://www.ncbi.nlm.nih.gov/pubmed/35462888
http://dx.doi.org/10.3389/fphar.2022.805344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022603/
https://www.ncbi.nlm.nih.gov/pubmed/35462888
http://dx.doi.org/10.3389/fphar.2022.805344

Ejemplares similares